These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 10761804

  • 1. Electropharmacologic effect of a standard dose of intravenous procainamide in patients with sustained ventricular tachycardia.
    Rials SJ, Britchkow D, Marinchak RA, Kowey PR.
    Clin Cardiol; 2000 Mar; 23(3):171-4. PubMed ID: 10761804
    [Abstract] [Full Text] [Related]

  • 2. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
    Sager PT, Nademanee K, Antimisiaris M, Pacifico A, Pruitt C, Godfrey R, Singh BN.
    Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
    [Abstract] [Full Text] [Related]

  • 3. The efficacy, electrophysiologic and electrocardiographic effects of intravenous pirmenol, a new class I antiarrhythmic agent, in patients with ventricular tachycardia: comparison with procainamide.
    Gold RL, Frumin H, Haffajee CI, Kerin NZ, Jarandilla R.
    Pacing Clin Electrophysiol; 1988 Mar; 11(3):308-14. PubMed ID: 2452418
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Electrophysiologic and clinical factors influencing response to class IA antiarrhythmic agents in patients with inducible sustained monomorphic ventricular tachycardia.
    Gold RL, Haffajee CI, Alpert JS.
    Am Heart J; 1986 Jul; 112(1):9-13. PubMed ID: 3728294
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
    Markel ML, Miles WM, Luck JC, Klein LS, Prystowsky EN.
    Circulation; 1993 Mar; 87(3):783-92. PubMed ID: 8443899
    [Abstract] [Full Text] [Related]

  • 11. Prolongation of ventricular refractoriness by class Ia antiarrhythmic drugs in the prevention of ventricular tachycardia induction.
    Kus T, Costi P, Dubuc M, Shenasa M.
    Am Heart J; 1990 Oct; 120(4):855-63. PubMed ID: 2220538
    [Abstract] [Full Text] [Related]

  • 12. Electrophysiologic mechanisms of antiarrhythmic efficacy of a sotalol and class Ia drug combination: elimination of reverse use dependence.
    Lee SD, Newman D, Ham M, Dorian P.
    J Am Coll Cardiol; 1997 Jan; 29(1):100-5. PubMed ID: 8996301
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Drug-induced narrowing of the width of the zone of entrainment as a predictor of the subsequent non-inducibility of reentrant ventricular tachycardia after an additional dose of an antiarrhythmic drug.
    Aizawa Y, Chinushi M, Naitoh N, Shibata A.
    Heart; 1996 Feb; 75(2):165-70. PubMed ID: 8673755
    [Abstract] [Full Text] [Related]

  • 18. Electropharmacologic testing in sustained ventricular tachycardia associated with coronary heart disease: value of the response to intravenous procainamide in predicting the response to oral procainamide and oral quinidine treatment.
    Oseran DS, Gang ES, Rosenthal ME, Mandel WJ, Peter T.
    Am J Cardiol; 1985 Nov 15; 56(13):883-6. PubMed ID: 3904387
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of an open-loop, computer-based infusion system designed to achieve a series of constant, targeted plasma procainamide concentrations in patients undergoing electrophysiologic testing.
    Coyle JD, Carnes CA, Schaal SF.
    Pharmacotherapy; 1997 Nov 15; 17(3):445-56. PubMed ID: 9165549
    [Abstract] [Full Text] [Related]

  • 20. Use-dependent prolongation of ventricular tachycardia cycle length by type I antiarrhythmic drugs in humans.
    Kidwell GA, Greenspon AJ, Greenberg RM, Volosin KJ.
    Circulation; 1993 Jan 15; 87(1):118-25. PubMed ID: 8418998
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.